HIF2 Inhibitor Joins the Kidney Cancer Armamentarium

被引:17
作者
Kaelin, William G., Jr. [1 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR-2; LINDAU TUMOR-SUPPRESSOR; PAS-B DOMAIN; TRANSCRIPTION FACTOR; HIF2-ALPHA; INACTIVATION; HIF-2-ALPHA; ANTAGONIST; MICE;
D O I
10.1200/JCO.2017.77.5254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:908 / +
页数:5
相关论文
共 32 条
[1]   HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses [J].
Bertout, Jessica A. ;
Majmundar, Amar J. ;
Gordan, John D. ;
Lam, Jennifer C. ;
Ditsworth, Dara ;
Keith, Brian ;
Brown, Eric J. ;
Nathanson, Katherine L. ;
Simon, M. Celeste .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) :14391-14396
[2]   Targeting renal cell carcinoma with a HIF-2 antagonist [J].
Chen, Wenfang ;
Hill, Haley ;
Christie, Alana ;
Kim, Min Soo ;
Holloman, Eboni ;
Pavia-Jimenez, Andrea ;
Homayoun, Farrah ;
Ma, Yuanqing ;
Patel, Nirav ;
Yell, Paul ;
Hao, Guiyang ;
Yousuf, Qurratulain ;
Joyce, Allison ;
Pedrosa, Ivan ;
Geiger, Heather ;
Zhang, He ;
Chang, Jenny ;
Gardner, Kevin H. ;
Bruick, Richard K. ;
Reeves, Catherine ;
Hwang, Tae Hyun ;
Courtney, Kevin ;
Frenkel, Eugene ;
Sun, Xiankai ;
Zojwalla, Naseem ;
Wong, Tai ;
Rizzi, James P. ;
Wallace, Eli M. ;
Josey, John A. ;
Xie, Yang ;
Xie, Xian-Jin ;
Kapur, Payal ;
McKay, Renee M. ;
Brugarolas, James .
NATURE, 2016, 539 (7627) :112-+
[3]   On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models [J].
Cho, Hyejin ;
Du, Xinlin ;
Rizzi, James P. ;
Liberzon, Ella ;
Chakraborty, Abhishek A. ;
Gao, Wenhua ;
Carvo, Ingrid ;
Signoretti, Sabina ;
Bruick, Richard K. ;
Josey, John A. ;
Wallace, Eli M. ;
Kaelin, William G., Jr. .
NATURE, 2016, 539 (7627) :107-+
[4]   Systemic Therapy for Metastatic Renal-Cell Carcinoma [J].
Choueiri, Toni K. ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04) :354-366
[5]   Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma [J].
Courtney, Kevin D. ;
Infante, Jeffrey R. ;
Lam, Elaine T. ;
Figlin, Robert A. ;
Rini, Brian I. ;
Brugarolas, James ;
Zojwalla, Naseem J. ;
Lowe, Ann M. ;
Wang, Keshi ;
Wallace, Eli M. ;
Josey, John A. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) :867-+
[6]   Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing [J].
Gerlinger, Marco ;
Horswell, Stuart ;
Larkin, James ;
Rowan, Andrew J. ;
Salm, Max P. ;
Varela, Ignacio ;
Fisher, Rosalie ;
McGranahan, Nicholas ;
Matthews, Nicholas ;
Santos, Claudio R. ;
Martinez, Pierre ;
Phillimore, Benjamin ;
Begum, Sharmin ;
Rabinowitz, Adam ;
Spencer-Dene, Bradley ;
Gulati, Sakshi ;
Bates, Paul A. ;
Stamp, Gordon ;
Pickering, Lisa ;
Gore, Martin ;
Nicol, David L. ;
Hazell, Steven ;
Futreal, P. Andrew ;
Stewart, Aengus ;
Swanton, Charles .
NATURE GENETICS, 2014, 46 (03) :225-+
[7]   Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].
Gerlinger, Marco ;
Rowan, Andrew J. ;
Horswell, Stuart ;
Larkin, James ;
Endesfelder, David ;
Gronroos, Eva ;
Martinez, Pierre ;
Matthews, Nicholas ;
Stewart, Aengus ;
Tarpey, Patrick ;
Varela, Ignacio ;
Phillimore, Benjamin ;
Begum, Sharmin ;
McDonald, Neil Q. ;
Butler, Adam ;
Jones, David ;
Raine, Keiran ;
Latimer, Calli ;
Santos, Claudio R. ;
Nohadani, Mahrokh ;
Eklund, Aron C. ;
Spencer-Dene, Bradley ;
Clark, Graham ;
Pickering, Lisa ;
Stamp, Gordon ;
Gore, Martin ;
Szallasi, Zoltan ;
Downward, Julian ;
Futreal, P. Andrew ;
Swanton, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892
[8]   HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma [J].
Gordan, John D. ;
Lal, Priti ;
Dondeti, Vijay R. ;
Letrero, Richard ;
Parekh, Krishna N. ;
Oquendo, C. Elisa ;
Greenberg, Roger A. ;
Flaherty, Keith T. ;
Rathmell, W. Kimryn ;
Keith, Brian ;
Simon, M. Celeste ;
Nathanson, Katherine L. .
CANCER CELL, 2008, 14 (06) :435-446
[9]  
Kaelin W, 2015, MOL BIOL KIDNEY CANC, P31
[10]   The concept of synthetic lethality in the context of anticancer therapy [J].
Kaelin, WG .
NATURE REVIEWS CANCER, 2005, 5 (09) :689-698